Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Canaccord Genuity Maintains Buy on Staar Surgical, Raises Price Target to $89
Canaccord Genuity analyst Jason Mills maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $81 to $89.
Needham Sees Clear View Into STAAR Surgical’s Durable Double-Digit Revenue Expansion
Needham is initiating coverage on STAAR Surgical Company (NASDAQ:STAA) with a Buy rating and an $87 price target. The analysts note…
Needham Initiates Coverage On Staar Surgical with Buy Rating, Announces Price Target of $87
Needham analyst David Saxon initiates coverage on Staar Surgical (NASDAQ:STAA) with a Buy rating and announces Price Target of $87.
50 Biggest Movers From Yesterday
Gainers
Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in Hycroft Mining Holding.
STAAR Surgical Announced U.S. FDA Approval of EVO Visian Implantable Collamer Lenses
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S.
BTIG Upgraded Staar Surgical Stock – Read Why
BTIG upgraded Implantable lenses-focused Staar Surgical Company (NASDAQ: STAA) to Buy from Neutral with a $98 price target.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.